Dr. Mathias Vormehr, Director Cancer Vaccines, BioNTech SE, is an immunologist currently leading the preclinical research on mRNA therapeutics such as next-generation personalized cancer vaccines or RNA-encoded cytokines at BioNTech. He performed his diploma thesis on immunotherapy at the German Cancer Research Center Heidelberg and received a doctorate in pharmacy from the University of Mainz. His work resulted in several patent applications as well as high impact publications in journals like Nature.